Analysis of Genes Associated with Both Neural Tube Defects and Neuroectodermal Tumors.
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
23 Mar 2022
23 Mar 2022
Historique:
entrez:
23
3
2022
pubmed:
24
3
2022
medline:
8
4
2022
Statut:
epublish
Résumé
BACKGROUND Previous studies have demonstrated that embryo development and the occurrence of tumors are closely related, as key genes, pathways, miRNAs, and other biological mechanisms are involved in both processes. Extensive research has found that abnormal development of nerve ectodermal cells not only leads to neural tube defects (NTDs), but also neuroectodermal tumors. MATERIAL AND METHODS Genes associated with both NTDs and neuroectodermal tumors were obtained from the DisGeNET database. The STRING database was used to construct the protein-protein interaction (PPI) network and the hub genes were visualized using Cytoscape. Additionally, we predicted the miRNAs targeting the identified genes. Sequencing data obtained from an NTDs mouse model and human samples were used to confirm the bioinformatics results. Moreover, a dual-luciferase report assay was used to validate the targeting relationship between the miRNA-gene pairs identified. RESULTS A total of 104 intersection genes of NTDs-related and neuroectodermal tumors-related genes were obtained; 20 of these genes were differentially expressed in NTDs samples and had very close interactions. Among 10 hub genes, we identified 3 important susceptibility genes differentially expressed both in RA-induced NTDs mice and human glioblastoma samples: Ncam1, Shh, and Ascl1. Among these, we found that the Ncam1 expression level was regulated by mmu-miR-30a-5p, and the Ascl1 expression level was regulated by mmu-miR-375-3p. CONCLUSIONS In conclusion, we identified differentially expressed genes and a potential miRNA-mediated regulation mechanism shared between NTDs and neuroectodermal tumors that may guide future studies aiming to find novel therapeutic targets for NTDs or neuroectodermal tumors.
Identifiants
pubmed: 35318299
pii: 936079
doi: 10.12659/MSM.936079
pmc: PMC8958863
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e936079Références
Cell Stem Cell. 2017 Aug 3;21(2):209-224.e7
pubmed: 28712938
Cell. 2020 Oct 15;183(2):377-394.e21
pubmed: 32976798
BMC Genomics. 2018 Jan 18;19(1):59
pubmed: 29347911
PLoS One. 2013 Aug 02;8(8):e69230
pubmed: 23936320
Semin Thromb Hemost. 2013 Nov;39(8):881-95
pubmed: 24108471
Neurol Clin. 2018 Aug;36(3):395-419
pubmed: 30072062
Int J Mol Sci. 2020 Nov 11;21(22):
pubmed: 33187334
Mech Ageing Dev. 2020 Jul;189:111286
pubmed: 32531293
Nat Commun. 2017 May 05;8:15182
pubmed: 28474670
Nat Rev Genet. 2021 May;22(5):307-323
pubmed: 33452500
Genes Cancer. 2011 Apr;2(4):431-42
pubmed: 21779511
JAMA Oncol. 2019 Aug 1;5(8):1150-1158
pubmed: 31219523
Hum Genet. 2005 Jul;117(2-3):133-42
pubmed: 15883837
Neoplasma. 2019 May 23;66(3):350-356
pubmed: 30784283
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Science. 2019 Dec 6;366(6470):1247-1251
pubmed: 31806814
BMJ. 2020 Dec 2;371:m4060
pubmed: 33268348
Semin Reprod Endocrinol. 1999;17(3):275-90
pubmed: 10797946
Versicherungsmedizin. 1998 Oct 1;50(5):173-9
pubmed: 9816989
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
pubmed: 29074454
Int J Mol Sci. 2019 Jul 26;20(15):
pubmed: 31357387
Development. 2017 Feb 15;144(4):552-566
pubmed: 28196803
IUBMB Life. 2017 Sep;69(9):706-719
pubmed: 28691208
Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):761-765
pubmed: 31169880
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Glia. 2020 Dec;68(12):2613-2630
pubmed: 32573857
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Front Physiol. 2019 Jul 11;10:705
pubmed: 31354503
CNS Drugs. 2017 Aug;31(8):675-684
pubmed: 28681349
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nature. 2021 Apr;592(7852):80-85
pubmed: 33692543
Neurol India. 2020 Sep-Oct;68(5):1144-1150
pubmed: 33109865
Brain Res. 2019 Feb 1;1704:174-186
pubmed: 30347220
Biochem Biophys Res Commun. 2017 Sep 30;491(4):946-952
pubmed: 28757413
Pediatr Neurosci. 1989;15(4):181-7
pubmed: 2562067
Genesis. 2021 Nov;59(11):e23459
pubmed: 34713546
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Nat Rev Cancer. 2002 Aug;2(8):616-26
pubmed: 12154354
Int J Cancer. 2008 Jul 15;123(2):322-329
pubmed: 18464291
Cell Death Dis. 2018 May 3;9(5):520
pubmed: 29725084
Database (Oxford). 2015 Apr 15;2015:bav028
pubmed: 25877637
Biomolecules. 2021 Jan 12;11(1):
pubmed: 33445626
Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):25-41
pubmed: 23224339
Wiley Interdiscip Rev Dev Biol. 2021 Jul;10(4):e394
pubmed: 32852143
Histol Histopathol. 2011 Aug;26(8):965-78
pubmed: 21692030
Nucleic Acids Res. 2020 Jan 8;48(D1):D845-D855
pubmed: 31680165
PLoS One. 2013 Aug 06;8(8):e70457
pubmed: 23936434
OMICS. 2018 Jun;22(6):437-448
pubmed: 29927716
Neurochem Res. 2020 Nov;45(11):2679-2690
pubmed: 32857295
Front Mol Neurosci. 2017 Jul 27;10:237
pubmed: 28798665
Neurochem Res. 2013 Aug;38(8):1605-15
pubmed: 23677776
Am J Pathol. 1983 Oct;113(1):117-24
pubmed: 6312802
Clin Lab. 2020 Jul 1;66(7):
pubmed: 32658431
Angiogenesis. 2019 May;22(2):211-221
pubmed: 30656567